Frozen Food Gift Group, Inc. (OTC: FROZ) - For an in-depth report on Frozen Food Gift Group, Inc. (follow: www.BullTrends.com/stockquote/FROZ
Shares of FROZ closed down 30.95% on Thursday with about 416 million shares traded. The stock was one of the biggest decliners in the OTC market. The company is preparing to change the name and ticker symbol of the Company from Frozen Food Gift Group, Inc. (OTC BB: FROZ) to a new name and stock symbol.
Teva Pharmaceutical Industries Limited (NYSE: TEVA) - For an in-depth report on Teva Pharmaceutical Industries Limited follow: www.BullTrends.com/stockquote/TEVA
Shares of Teva Pharmaceutical Industries closed up 4.32% on about 13 million shares traded. The stock was one of the most active stocks on the NYSE. The company’s first-quarter earnings rose 8 percent which beat analyst estimates. The company said in a statement that profit excluding some costs rose to $1 billion, or $1.22 a share, from $960 million, or $1.12, a year earlier. An average of 20 estimates by analysts compiled by Bloomberg had predicted $1.20.
Avon Products Inc. (NYSE: AVP) - For an in-depth report on Avon Products Inc. follow: www.BullTrends.com/stockquote/AVP
Shares of Avon Products Inc. closed down 10.21% on about 21 million shares traded. The stock was one of the biggest decliners on the NYSE and hit a new yearly low of $13.22 during intra-day trading. The company has agreed to pay $135 million to finally settle an investigation by the federal government into whether Avon paid bribes in countries including China to gain favors.
Catamaran Corporation (NASDAQ: CTRX) - For an in-depth report on Catamaran Corporation follow: www.BullTrends.com/stockquote/CTRX
Shares of CTRX closed up nearly 13% on Thursday with nearly 9 million shares traded. The stock was one of the biggest gainers on the NASDAQ. The company reported first quarter earnings that beat on both the top and bottom lines. Revenue jumped 53% year over year to $4.9 billion, while adjusted EPS climbed 16% to $0.50 per share.
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.